Carmignac Gestion Haemonetics Corp Transaction History

Carmignac Gestion

  • $5.82 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$51.81 - $118.56 $22.8 Million - $52.2 Million
-440,139 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$111.01 - $139.48 $14.9 Million - $18.8 Million
134,592 Added 44.05%
440,139 $48.9 Million
Q4 2020

Feb 12, 2021
BUY
$88.75 - $119.95 $27.1 Million - $36.7 Million
305,547 New
305,547 $36.3 Million

Others Institutions Holding HAE

# of Institutions
333
Shares Held
54M
Call Options Held
689K
Put Options Held
345K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.36B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email